For instance, recombinant CXCL13 promoted TLS formation and CD8+ T cell infiltration in ovarian cancer [205, 206], and co‐injection of CXCL13 and CCL21 with gemcitabine significantly enhanced TLS formation in pancreatic cancer models [207]. This evidence concerns the gene CXCL13 and ovarian carcinoma.